A detailed history of Cherry Creek Investment Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Cherry Creek Investment Advisors, Inc. holds 778 shares of AMGN stock, worth $220,072. This represents 0.13% of its overall portfolio holdings.

Number of Shares
778
Previous 775 0.39%
Holding current value
$220,072
Previous $242,000 3.31%
% of portfolio
0.13%
Previous 0.13%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$309.38 - $337.38 $928 - $1,012
3 Added 0.39%
778 $250,000
Q2 2024

Jul 17, 2024

SELL
$262.75 - $319.31 $19,443 - $23,628
-74 Reduced 8.72%
775 $242,000
Q1 2024

Apr 23, 2024

SELL
$268.87 - $324.56 $26,080 - $31,482
-97 Reduced 10.25%
849 $241,000
Q4 2023

Jan 26, 2024

BUY
$255.7 - $288.46 $1,022 - $1,153
4 Added 0.42%
946 $272,000
Q3 2023

Oct 13, 2023

BUY
$218.65 - $271.46 $437 - $542
2 Added 0.21%
942 $253,000
Q2 2023

Jul 14, 2023

BUY
$214.27 - $253.37 $1,071 - $1,266
5 Added 0.53%
940 $208,000
Q1 2023

Apr 24, 2023

BUY
$225.79 - $275.2 $677 - $825
3 Added 0.32%
935 $226,000
Q4 2022

Feb 10, 2023

SELL
$229.03 - $291.01 $12,825 - $16,296
-56 Reduced 5.67%
932 $244,000
Q3 2022

Oct 24, 2022

BUY
$224.46 - $253.15 $673 - $759
3 Added 0.3%
988 $223,000
Q2 2022

Jul 20, 2022

BUY
$230.71 - $256.74 $922 - $1,026
4 Added 0.41%
985 $240,000
Q1 2022

Apr 22, 2022

BUY
$219.27 - $242.57 $657 - $727
3 Added 0.31%
981 $237,000
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $194,504 - $222,592
978 New
978 $220,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $151B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cherry Creek Investment Advisors, Inc. Portfolio

Follow Cherry Creek Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cherry Creek Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cherry Creek Investment Advisors, Inc. with notifications on news.